Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced

Di Fei Sun1, Yoshihide Fujigaki, Taiki Fujimoto

  • 1First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.

Insights

Mycophenolate mofetil (MMF) impaired renal tissue repair in acute renal failure by reducing myofibroblasts and macrophages. This suggests these cells are crucial for kidney recovery after injury.

Area of Science:

  • Nephrology
  • Cell Biology
  • Immunology

Background:

  • Acute renal failure (ARF) involves complex cellular responses.
  • Interstitial myofibroblasts and macrophages are implicated in renal recovery.
  • Uranyl acetate (UA) is a model toxin for inducing ARF.

Purpose of the Study:

  • To investigate the role of mycophenolate mofetil (MMF) in renal tissue repair following UA-induced ARF.
  • To determine if MMF, by modulating immune cell infiltration, affects kidney regeneration.

Main Methods:

  • Rats with UA-induced ARF were treated with MMF or vehicle.
  • Renal tissues were analyzed for cell proliferation (BrdU, Ki67), macrophages (ED1), myofibroblasts (alpha-SMA), and lymphocytes (CD43).
  • Alpha-SMA mRNA expression and serum creatinine were assessed.

Main Results:

  • MMF treatment reduced macrophages and myofibroblasts, correlating with impaired proximal tubule regeneration.
  • Serum creatinine and tubular damage scores were higher in MMF-treated rats at later time points.
  • Lymphocyte infiltration was reduced by MMF but did not appear to impact early regeneration.

Conclusions:

  • Transient myofibroblasts and macrophages in the renal interstitium may promote regenerative repair in UA-induced ARF.
  • MMF's inhibition of these cells hinders kidney tissue repair.
  • Targeting interstitial cellular responses could be a therapeutic strategy for ARF.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...